Not yet recruitingPhase 2NCT05402384

AVTX-801 D-galactose Supplementation in SLC35A2-CDG

Studying Congenital disorder of glycosylation

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Eva Morava-Kozicz
Principal Investigator: Eva Morava-Kozicz, MD, PhD
Icahn School of Medicine at Mount Sinai
Intervention: AVTX-801(drug)
Enrollment: 10 enrolled
Eligibility: All sexes
Timeline: 2027 – 2028

Study locations (1)

Mayo Clinic Minnesota, Rochester, Minnesota, United States

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS) · Rare Diseases Clinical Research Network · Children's Hospital of Philadelphia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05402384 on ClinicalTrials.gov

← Back to all trials